PSNLPersonalis, Inc.
Price
+162%1YEnd-of-day closes, not the intraday tick.
Accounting is the story here: start there
Quality mixed, hard red flags, growth fading, the market undecided.
NeXT Personal Dx is a tumor-informed liquid biopsy test for the detection of minimal residual disease ("MRD") and recurrence monitoring. We believe NeXT Personal Dx, which was introduced in the fourth quarter of 2023, is the first ultrasensitive test on the market to detect MRD and monitor therapy response in patients with solid tumor cancers. NeXT Personal Dx has been shown to potentially detect cancer recurrence ahead of traditional imaging and is designed to aid decision making throughout a patient's cancer journey.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Personalis, Inc. (PSNL) reported revenue of $22M in Q2 2026 (quarter ended Jun 30, 2026), up 30% from the same quarter a year earlier. That came with a gross margin of 21% and net loss of $32M. For the full year FY2025, revenue was $70M (−18% year on year) and net income −$81M. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 6, 2026As previously disclosed, on July 20, 2026, Personalis, Inc., a Delaware corporation (“Personalis” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Tempus AI, Inc., a Nevada corporation (“Tempus” or “Parent”), Aviary Development, Inc., a Delaware corporation and a direct …Other event · Form 8-K
- Aug 20, 2026On August 20, 2026, Personalis, Inc. received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA's Million Veteran Program (VA MVP)Other event · Form 8-K
- Aug 4, 2026Personalis Reports Second Quarter Results and Recent Highlights.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Diagnostics & Research
Ranks #21 of 21 by RyuScore